List of Excipients in API sulfasalazine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sulfasalazine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | AZULFIDINE | sulfasalazine | 0013-0101 | MAGNESIUM STEARATE | |
| Pfizer Laboratories Div Pfizer Inc | AZULFIDINE | sulfasalazine | 0013-0101 | POVIDONE | |
| Pfizer Laboratories Div Pfizer Inc | AZULFIDINE | sulfasalazine | 0013-0101 | SILICON DIOXIDE | |
| Pfizer Laboratories Div Pfizer Inc | AZULFIDINE | sulfasalazine | 0013-0101 | STARCH, CORN | |
| Pfizer Laboratories Div Pfizer Inc | AZULFIDINE | sulfasalazine | 0013-0102 | CARNAUBA WAX | |
| Pfizer Laboratories Div Pfizer Inc | AZULFIDINE | sulfasalazine | 0013-0102 | CELLACEFATE | |
| Pfizer Laboratories Div Pfizer Inc | AZULFIDINE | sulfasalazine | 0013-0102 | GLYCERYL STEARATE SE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing sulfasalazine
Detailed excipient profiles for sulfasalazine
Excipient focus: CARNAUBA WAX
sulfasalazine drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | sulfasalazine | 0013-0102 |
| Greenstone LLC | sulfasalazine | 59762-0104 |
| >Company | >Ingredient | >NDC |
sulfasalazine drug variants not containing CARNAUBA WAX
Excipient focus: CELLACEFATE
sulfasalazine drug variants containing CELLACEFATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | sulfasalazine | 0013-0102 |
| Greenstone LLC | sulfasalazine | 59762-0104 |
| >Company | >Ingredient | >NDC |
sulfasalazine drug variants not containing CELLACEFATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
sulfasalazine drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | sulfasalazine | 10544-288 |
| Aidarex Pharmaceuticals LLC | sulfasalazine | 33261-756 |
| >Company | >Ingredient | >NDC |
sulfasalazine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
sulfasalazine drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | sulfasalazine | 10544-288 |
| Aidarex Pharmaceuticals LLC | sulfasalazine | 33261-756 |
| >Company | >Ingredient | >NDC |
sulfasalazine drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: GLYCERYL MONOSTEARATE
sulfasalazine drug variants containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Greenstone LLC | sulfasalazine | 59762-0104 |
| >Company | >Ingredient | >NDC |
sulfasalazine drug variants not containing GLYCERYL MONOSTEARATE
Excipient focus: GLYCERYL STEARATE SE
sulfasalazine drug variants containing GLYCERYL STEARATE SE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | sulfasalazine | 0013-0102 |
| >Company | >Ingredient | >NDC |
sulfasalazine drug variants not containing GLYCERYL STEARATE SE
Excipient focus: MAGNESIUM STEARATE
sulfasalazine drug variants containing MAGNESIUM STEARATE
sulfasalazine drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
sulfasalazine drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Greenstone LLC | sulfasalazine | 59762-0104 |
| >Company | >Ingredient | >NDC |
sulfasalazine drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 20000
sulfasalazine drug variants containing POLYETHYLENE GLYCOL 20000
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | sulfasalazine | 0013-0102 |
| >Company | >Ingredient | >NDC |
sulfasalazine drug variants not containing POLYETHYLENE GLYCOL 20000
Excipient focus: POVIDONE
sulfasalazine drug variants containing POVIDONE
sulfasalazine drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
sulfasalazine drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | sulfasalazine | 10544-288 |
| Aidarex Pharmaceuticals LLC | sulfasalazine | 33261-756 |
| >Company | >Ingredient | >NDC |
sulfasalazine drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
sulfasalazine drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | sulfasalazine | 0013-0102 |
| Greenstone LLC | sulfasalazine | 59762-0104 |
| >Company | >Ingredient | >NDC |
sulfasalazine drug variants not containing PROPYLENE GLYCOL
Excipient focus: SILICON DIOXIDE
sulfasalazine drug variants containing SILICON DIOXIDE
sulfasalazine drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
sulfasalazine drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | sulfasalazine | 0093-3234 |
| Bryant Ranch Prepack | sulfasalazine | 63629-9715 |
| REMEDYREPACK INC | sulfasalazine | 70518-3732 |
| >Company | >Ingredient | >NDC |
sulfasalazine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
sulfasalazine drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
sulfasalazine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
sulfasalazine drug variants containing STARCH, CORN
sulfasalazine drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | sulfasalazine | 43353-495 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
sulfasalazine drug variants containing STEARIC ACID
sulfasalazine drug variants not containing STEARIC ACID
Excipient focus: TALC
sulfasalazine drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | sulfasalazine | 0013-0102 |
| Blenheim Pharmacal Inc | sulfasalazine | 10544-288 |
| Aidarex Pharmaceuticals LLC | sulfasalazine | 33261-756 |
| Greenstone LLC | sulfasalazine | 59762-0104 |
| >Company | >Ingredient | >NDC |
sulfasalazine drug variants not containing TALC
Excipient focus: WHITE WAX
sulfasalazine drug variants containing WHITE WAX
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | sulfasalazine | 0013-0102 |
| Greenstone LLC | sulfasalazine | 59762-0104 |
| >Company | >Ingredient | >NDC |
sulfasalazine drug variants not containing WHITE WAX
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
